FDA Adverse Event Injury Summary report: N

PRECISION®

MDR report key: 2151752 · Received July 6, 2011

Report

Report Number
3006630150-2011-01004
Event Type
Injury
Date Received
July 6, 2011
Date of Event
June 13, 2011
Report Date
June 14, 2011
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: MODEL # SC-2158-50, (B)(4), DESCRIPTION: LINEAR LEAD, 50 CM WITH PRE-LOADED 0.014 INCH STYLET THE EXPLANTED DEVICES WERE NOT RETURNED TO BSN AS THEY WERE DISCARDED BY THE MEDICAL FACILITY.

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING DOCUMENTATION FOR THE IPG AND LEADS REVEALED THAT NO ANOMALIES OR DEVIATIONS POTENTIALLY RELATED TO THE EVENT OCCURRED DURING MANUFACTURING. A REVIEW OF THE STERILIZATION DOCUMENTATION FOR THE IPG AND LEADS FOUND THEM TO BE SATISFACTORY.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT WAS EXPLANTED DUE TO AN INFECTION AT THE IPG SITE. THE PATIENT'S SYMPTOMS INCLUDED PUS, REDNESS, AND SWELLING AROUND THE IPG SITE. THE PHYSICIAN DOES NOT BELIEVE THE INFECTION WAS DEVICE OR PROCEDURE RELATED. THE POCKET WAS FLUSHED OUT AND THE PATIENT WAS GIVEN ORAL ANTIBIOTICS. THE PATIENT WAS REPORTEDLY DOING WELL FOLLOWING THE PROCEDURE.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT WAS EXPLANTED DUE TO AN INFECTION AT THE IPG SITE. THE PATIENT'S SYMPTOMS INCLUDED PUS, REDNESS, AND SWELLING AROUND THE IPG SITE. THE PHYSICIAN DOES NOT BELIEVE THE INFECTION WAS DEVICE OR PROCEDURE RELATED. THE POCKET WAS FLUSHED OUT AND THE PATIENT WAS GIVEN ORAL ANTIBIOTICS. THE PATIENT WAS REPORTEDLY DOING WELL FOLLOWING THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PRECISION® SPINAL CORD STIMULATOR LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1110-02 N/A

Patients

Seq Age Sex Outcome Treatment
1 82 YR Required Intervention